Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

Add To Watchlist

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > $4.13

View:

Post by crow27 on Jan 11, 2021 4:34pm

$4.13

Is much better than $3.40. It traded that low just 13 trading days ago. People are interested and that's what counts.

225

Comment

Comment by 3burtc on Jan 11, 2021 4:47pm

Investors see through the lies. Everyone and their dogs knows no delusion happened or will happen. Just strait up lies. The tiny delay is nothing compared to the billions, & billions that we be made. Glt the new guys & girls & welcome.

247

Comment

Comment by ABCs123s on Jan 11, 2021 6:26pm

I mean dilution did happen post phase 2 results, but will dilution happen? That certainly is a possibility, they still need cash to cover phase 3, if theirs no partner/buyout. Theirs also a possibility of dilution with the amalgation of holdings into therapeutics.

226

Comment

Comment by MrMugsy on Jan 11, 2021 6:55pm

Yes ... need to assume the company will be able to get the share price up and there will also be some dilution coming. Hoping it to be a smaller dilution based on share price appreciation ... to keep the ship running. Hey, if they can make it happen without dilution, great! But probably not the best assumption to make at this time. IMO ----

250

Comment